Pharmaceutical Technology on MSN2d
TC BioPharm signs LoI to acquire ophthalmic pharma company
TC BioPharm (TCBP) has signed a non-binding letter of intent (LoI) to acquire an ophthalmic pharmaceutical company focused on ...
Optometry Advisor3d
In Modern Myopia Management, Optometrists Have The Tools, The Talent, And The Evidence
With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...
TC BioPharm executes LOI to acquire ophthalmic pharma firm
TC BioPharm (NASDAQ:TCBP) has executed a non-binding letter of intent to  acquire a commercial-stage ophthalmic pharmaceutical company via an all-stock transaction. The purchase is part of TC BioPharm ...